Clinical Trial Update: ECC5004 DDI Study With Atorvastatin, Rosuvastatin, Digoxin and Midazolam in Healthy Participants [Phase 1]

View source ↗

Summary

Phase 1 study evaluating potential drug-drug interactions between ECC5004 and four concomitant medications (atorvastatin, rosuvastatin, digoxin, midazolam) in h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• DIGOXIN (Digoxin)
• ECC5004
• Midazolam (Midazolam)
• Rosuvastatin (rosuvastatin)
• atorvastatin (atorvastatin)

Snippet

Sponsor: Eccogene | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED